Interleukin-27 receptor: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 15:33, 17 March 2025
Interleukin-27 receptor (also known as IL-27R) is a type of protein that in humans is encoded by the IL27RA gene. It is a component of the immune system, playing a crucial role in the regulation of immune response.
Structure[edit]
The IL-27R is a heterodimeric receptor complex composed of two distinct subunits: IL-27Rα (also known as WSX-1 or TCCR) and glycoprotein 130 (gp130). The IL-27Rα subunit is unique to the IL-27R, while the gp130 subunit is shared with other members of the interleukin-6 (IL-6) family of cytokine receptors.
Function[edit]
The primary function of the IL-27R is to mediate the biological activities of interleukin-27 (IL-27), a cytokine produced by antigen-presenting cells. Upon binding of IL-27, the IL-27R initiates a cascade of intracellular signaling events, leading to the activation of JAK-STAT signaling pathway, which in turn regulates the expression of genes involved in immune responses.
Clinical significance[edit]
Alterations in the function or expression of the IL-27R have been implicated in a variety of autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. In addition, the IL-27R has been suggested as a potential therapeutic target for the treatment of these diseases.
See also[edit]
References[edit]
<references group="" responsive="1"></references>

